An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study

NCT05192200 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatomyositis

Interventions

DRUG: Anti-Beta Interferon (PF-06823859)

Sponsor

Pfizer